About K2M
K2M is a publicly listed company based in Leesburg (United States) founded in 2004, and was acquired by Stryker in August 2018. Devices for complex spinal disorders are developed using advanced technologies. It operates in the Healthcare and Technology sectors. K2M has raised $21.5 million across 2 funding rounds from investors including Stryker, Welsh, Carson, Anderson & Stowe and Ferrer Freeman & Company. The company has 426 employees. K2M has completed 1 acquisition, including Cardinal Spine. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its competitors include Nevro, Vertos Medical and Paradigm Spine; 3 of its 3 listed competitors have raised funding.
Company details
K2M was founded in 2004 in Leesburg, United States, focusing on the medical device sector for spine surgery. Products for complex spine and minimally invasive technologies are developed, including platform innovations such as Lamellar Titanium Technology for 3D-printed implants and tifix Locking Technology. The MESA spinal system is also offered. Operations center on providing tools for surgeons, with the company going public in May 2014.
- Annual Revenue$258.03 M (USD)9as on Dec 31, 2017
- Net Profit-$37.15 M (USD)11as on Dec 31, 2017
- EBITDA-$33.46 M (USD)4as on Dec 31, 2017
- Total Equity Funding$21.5M (USD)
in 2 rounds
- Latest Funding Round$75M (USD), Post-IPO
Jul 2018
- InvestorsStryker
& 2 more
- Employee Count426
- Investments & Acquisitions
- Acquired by
Funding Insights of K2M
K2M has successfully raised a total of $21.5M across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $75 million completed in July 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $21.5M
- Total Rounds 2
- Last Round Post-IPO — $75M
- First Round $21.5M
(Jun 2006)
- Investors Count 1
All 2 funding rounds of K2M with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2018 | $75M | Post-IPO | – | – | – |
| Jun 2006 | $21.5M | Series B | – | – |
3 investors in total: 3 institutional.
Investors in K2M
K2M has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Stryker, Welsh, Carson, Anderson & Stowe and Ferrer Freeman & Company.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
PE firm investing in the US | ffandco.com | Greenwich, United States | ||
Healthcare and technology sectors are targeted for private equity investments. | 1979 | wcas.com | New York, United States | |
3D-printed orthopedic products are manufactured for medical applications. | 1941 | stryker.com | Kalamazoo, United States |
Investor details for K2M
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of K2M
905 people are tracked at K2M (340 in leadership, 11 in board & advisors, 554 in team); the tracked headcount is 426.
| Name | Role | Group |
|---|---|---|
Glenn S. Boehnlein | VP & CFO | Leadership |
Stacie Ferschweiler | Vice President Human Resources | Leadership |
Satoshi Ogawa | Senior Director, IT Business Partner, Japan | Leadership |
Viju Menon | Group President, Global Quality and Operations | Leadership |
Kelly Shepard | Vice President, Global HR Operations | Leadership |
Satoshi Mizusawa | President & Representative Director | Leadership |
Alan Douville | VP, Chief Information Officer & Chief Information Security Officer | Leadership |
Rakesh Kumar | Director, Information Technology | Leadership |
Barry Welsh | Director Of Strategic Sales | Leadership |
Amyee Delaney | Director, Learning And Development Operations | Leadership |
Azzurra Taccia | Principal Talent Acquisition Business Partner | Leadership |
April Smith Phr | Senior Talent Acquisition Business Partner | Leadership |
Kim Montagnino | Chief Communications Officer | Leadership |
Rob Moore | Vice President Of Sales, Upper Extremities | Leadership |
Charlie Maher | Vice President, North America Sales, Joint Replacement | Leadership |
Suresh Munuma | Sr. Director - IT Data & Analytics | Leadership |
Spencer Stiles | Group President, Orthopaedics and Spine Group | Leadership |
Ric Stevens | Principal Talent Acquisition Business Partner | Leadership |
Pedro Ramazzotti | Vice President General Manager Stryker Latam | Leadership |
Shelby Sweeney | Senior Director Human Resources | Leadership |
885 more people are available in the full profile.
Complete people profiles for K2M
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of K2M
K2M is a publicly listed company on the NASDAQ with ticker symbol KTWO in USA, operating in the Finance sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date09 May 2014
- Listed onNASDAQ: KTWO
- Listed entityK2 CAPITAL ACQUISITION CORPORATION
- Exchange sectorFinance
- ISINKYG5226B1059
- Share price$10.09 (+0.15% on the day) · 2026-10-13
- Market capitalisation$202.1M
- Price to earnings140.7
- EPS (diluted, trailing year)$0.07
- Volume (last session)16,688
Investments & Acquisitions by K2M
K2M has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cardinal Spine.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Interbody fusion devices are developed to stabilize spinal implants. | cardinalspine.net | Louisville, United States | 2008 | Oct 2017 | •••• |
Complete acquisition details for K2M
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of K2M
7 dated milestones of K2M across 14 years, from founding to its latest funding, stage changes and deals.
- Founded K2M is founded.
- Funding First funding round of $21.5M.
- Exit Acquired by Welsh, Carson, Anderson & Stowe.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Cardinal Spine.
- Funding Latest funding round, Post-IPO, of $75.0M.
- Exit Acquired by Stryker.
Competitors of K2M
K2M has 3 listed competitors in our database, 3 of them funded. They include Nevro, Vertos Medical and Paradigm Spine.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nevro.com | 2006 | Menlo Park, United States | $154.1M | 1,215 | Provider of high-frequency spinal cord stimulation implants | |
| vertosmed.com | 2005 | Aliso Viejo, United States | $177.75M | 140 | Minimally invasive treatments for lumbar spinal stenosis are developed. | |
| paradigmspine.com | 2005 | New York, United States | $142.15M | 43 | Stabilization devices for healthcare are manufactured by the company. |
Detailed competitors of K2M
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of K2M
Websites that share an audience with K2M (k2m.com).
Websites whose visitors overlap most with K2M. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
zimmer.com | zimmer.com | 100% | #1,979,435 | – | |
| medtronic.com | 99% | 2.6M | #22,622 | View details | |
| stryker.com | 91% | 1.1M | #56,352 | View details | |
alphatecspine.com | alphatecspine.com | 84% | #3,976,987 | – | |
| biomet.com | 78% | 1.7K | #10,154,264 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 13 similar websites and full traffic analytics for K2M
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 13 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
3 companies that operate in the same segment as K2M (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about K2m
Complete news archive for K2M
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about K2M
K2M was founded in 2004 and raised its 1st funding round 2 years after it was founded.
K2M is headquartered in Leesburg, United States. It is registered at Leesburg, Virginia, United States.
K2M is a funded company, having raised a total of $21.5M across 2 funding rounds to date. The company's 1st funding round was a Series B of $21.5M, raised on Jun 2006.
K2M has 426 employees.
Annual revenue of K2M is $258.03M as on Dec 31, 2017.
K2M was founded in 2004 in Leesburg, United States, focusing on the medical device sector for spine surgery. Products for complex spine and minimally invasive technologies are developed, including platform innovations such as Lamellar Titanium Technology for 3D-printed implants and tifix Locking Technology. The MESA spinal system is also offered. Operations center on providing tools for surgeons, with the company going public in May 2014.
K2M's top competitors include Nevro, Paradigm Spine and Vertos Medical.
Yes, K2M is publicly traded on NASDAQ under the ticker symbol KTWO.
K2M has made 1 acquisition, including Cardinal Spine.
K2M has 3 investors. Key investors include Stryker, Welsh, Carson, Anderson & Stowe, and Ferrer Freeman & Company.
Yes. K2M was acquired by Stryker in August 2018.